PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1980.09%
5Y revenue/share CAGR above 1.5x ANO.AX's 132.78%. David Dodd would look for consistent product or market expansions fueling outperformance.
36.51%
3Y revenue/share CAGR at 50-75% of ANO.AX's 55.70%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
-70.40%
Negative 5Y OCF/share CAGR while ANO.AX is at 140.02%. Joel Greenblatt would question the firm’s operational model or cost structure.
-87.67%
Negative 3Y OCF/share CAGR while ANO.AX stands at 204.68%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
56.00%
Below 50% of ANO.AX's 564.78%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-1200.00%
Negative 3Y CAGR while ANO.AX is 1237.08%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
18194.23%
5Y equity/share CAGR above 1.5x ANO.AX's 81.46%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
265.66%
3Y equity/share CAGR above 1.5x ANO.AX's 71.78%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
164.97%
AR growth of 164.97% while ANO.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.74%
Debt growth of 0.74% while ANO.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.